Seres Therapeutics Inc (NASDAQ: MCRB) Has Fallen -792.21% From Its Highs, What Comes Next?
Seres Therapeutics Inc (NASDAQ:MCRB)’s traded shares stood at 3.01 million during the last session, with the company’s beta value hitting 2.22. At the close of